SYNTHESES OF 3',4'-DIDEOXY AND S'^^'-TRIDEOXYRIBOSTAMYCIN
ACTIVE AGAINST KANAMYCIN-RESISTANT E. COLI AND P. AERUGINOSA Sir: Recent studies on synthetic deoxy derivatives of aminoglycosidic antibiotics such as S'-deoxykanamycin1), S'^'-dideoxykanamycin B2) and S'^-dideoxyneamine^have confirmed that removal of the hydroxyl group which is phosphorylated by drug-resistant bacteria from kanamycins gives compounds active against the resistant organisms. As an extension of this work, we describe in this paper the syntheses of two deoxy-derivatives of ribostamycin4). If inactivation of ribostamycin by Escherichia coli K12-ML 1629 and K12-ML 1630 carrying R factor (see Table 1 ) is caused by phosphorylation at the 3'-hydroxyl group of the antibiotic, dehydroxylation at the S'-position might give an antibiotic active against resistant organisms.
Ribostamycin can be convent ently converted to 3',4'-dideoxy and 3',4',5"-trideoxyribostamycin, in which hydroxyl groups at C-4' or C-4' and C-5" are removed in addition to the 3r-hydroxyl group.
Ribostamycin was treated with benzyloxyĉ arbonyl chloride in aqueous methanol to give tetra-N-benzyloxycarbonylribostamycin (1) Table 1 . It is further noteworthy that, though both the parent antibiotic and its 3',4'-dideoxy derivative are inactive against E. coli K12-ML 1629 and K12-ML 1630 carrying R factor, the 3',4'-dideoxy derivative shows activity against E. coli JR66/W677 which is known to be resistant5) to S'^-dideoxykanamycin B and kanamycins.
On the other hand, S',4',5"-trideoxyribostamycin showed decreased antibacterial activity as compared with the parent antibiotic, but it did show weak activity against both resistant and sensitive strains of E. coli.
These results suggest that E. coli K12-ML 1629 and K12-ML 1630, resistant to kanamycins but sensitive to 3r-deoxykanamycin, 3',4'-dideoxykanamycin B and 3',4'- 
